Establishment of Abbreviated Pancreatobiliary MRI Protocol

Seoul National University Hospital30 enrolled

Overview

This study aims to establish abbreviated PB MRI protocol for patients on regular imaging follow-up for pancreas cystic neoplasm.

Study Type

INTERVENTIONAL

Allocation

Purpose

OTHER

Masking

NONE

Enrollment

Conditions

Pancreas Cyst Intraductal Papillary Mucinous Neoplasm

Interventions

Abbreviated PB MRIDIAGNOSTIC_TEST

Abbreviated PB MRI which targets table time of 10 minutes. For MRI acquisition, standard dose of commercially available MR contrast agent (Gadovist, Bayer, Germany) is used on weight-based dosing (0.1mmol/kg).

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * on follow-up for pancreas intraductal mucinous neoplasm * OR incidentally detected pancreas cyst (equal to or larger than 1cm) * AND scheduled for CECT or has CECT within a months * AND sign informed consent Exclusion Criteria: * Any absolute or relative contra-indication for contrast-enhanced MRI * No pancreas cystic neoplasm * History of pancreatectomy * History of any procedure for pancreatic cyst (ablation, aspiration...) in a year * Hemosiderosis * Suspicion of acute pancreatitis

Locations (1)

Seoul National University Hospital

Seoul, South Korea

Outcomes

Primary Outcomes

Table time of Abbreviated PB MRI

total scan time

Time frame: 1 day after PB MRI acquisition

Secondary Outcomes

In room time of Abbreviated PB MRI

time spent in room by participants (difference between walk-in and walk-out times)

Time frame: 1 day after PB MRI acquisition

Diagnostic confidence

subjective diagnostic confidence for pancreas cystic neoplasm on five point scale

Time frame: 6 months after participants enrollment

Image quality

overall image quality of Abbreviated PB MRI

Time frame: 6 months after participants enrollment

Requirement for re-examination

clinical need for re-examination due to suboptimal image quality

Time frame: 6 months after participants enrollment

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.